HKG: 0690

Company Deals

Uni-Bio Science Partners with Sinovac to Expand Teriparatide Injection Globally

Fineline Cube Oct 15, 2025

Uni-Bio Science Group Limited (HKG: 0690), a China-based company, announced on September 12, 2025, that...

Company Drug

Uni-Bio Science’s Generic Diquas Accepted for NMPA Review

Fineline Cube May 23, 2025

China’s Uni-Bio Science Group (HKG: 0690) announced that a market filing for its generic version...

Company Drug Medical Device

Uni-Bio Science Group Achieves Milestones in Medical Aesthetics with New Product Approvals

Fineline Cube Dec 3, 2024

China-based Uni-Bio Science Group Limited (HKG: 0690) has announced two significant achievements in the medical...

Company Drug

Uni-Bio Science Group Wins NMPA Nod for Generic Forteo Injection for Osteoporosis

Fineline Cube Jan 22, 2024

Hong Kong-listed biopharmaceutical company Uni-Bio Science Group Ltd (HKG: 0690) has announced that it has...

Company Drug

InnoCare’s Zurletrectinib Wins NMPA Nod as China’s First Next-Gen TRK Inhibitor

Company Deals

Brii Biosciences Taps OpenBench AI Platform to Accelerate Drug Discovery

Company Deals

GSK Terminates Ideaya Synthetic Lethality Partnership, Returns Two Clinical Programs

Company Deals

B&K Corporation Debuts on HKEX in $900M IPO Backed by Burn Drug Pipeline